Related Experiment Video
Updated: May 19, 2026

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Angiogenesis in neurological disorders: a review
Göksemin Acar1, Gamze Tanrıöver, Ramazan Demir
1Department of Neurology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. goksemind@yahoo.com
Neurological Research
|August 15, 2012
Summary
New blood vessel formation (angiogenesis) aids tumor spread. This review explores how angiogenesis modulators impact cancer metastasis and neurological disorders, offering insights for cancer therapy.
Area of Science:
- Oncology
- Vascular Biology
- Neurology
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for tumor metastasis, enabling cancer cells to enter circulation.
- Tumor vascular density is a prognostic indicator of metastatic potential.
- Tumor-derived angiogenesis modulators are key to understanding tumor-regulated angiogenesis.
Purpose of the Study:
- To review the role of angiogenesis modulation in cancer metastasis.
- To discuss the implications of angiogenesis in neurological disorders.
- To explore the potential impact of angiogenesis modulation on cancer therapy.
Main Methods:
- Literature review of studies on angiogenesis and cancer.
- Analysis of observations concerning angiogenesis modulators.
- Discussion of implications in neurological disorders and cancer therapy.
Main Results:
- Angiogenesis is essential for tumor cell dissemination via new blood vessels.
- Vascular density in primary tumors correlates with metastatic incidence.
- The direct link between induced angiogenesis and tumor malignancy progression requires further understanding.
Conclusions:
- Understanding angiogenesis modulation is vital for cancer therapy and neurological disorder research.
- Targeting angiogenesis pathways may offer novel therapeutic strategies for cancer.
- Further research is needed to fully elucidate the connection between angiogenesis and tumor malignancy.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
The Blood-brain Barrier
Overview
